House committees step up investigation into FDA approval of controversial Alzheimer’s drug

The agency’s accelerated approval of the medication was welcomed by some advocates and doctors as a step forward in treating the devastating disease but strongly criticized by many experts who say the medication hasn’t been shown to be effective.

Read the full post at Health
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive